- Chemical Name:(1R)-1-phenylethanamine
- CAS No.:3886-69-9
- Molecular Formula:C8H11N
- Molecular Weight:121.182
- Hs Code.:29214980
- European Community (EC) Number:223-423-4
- UNII:V022ZK8GZ5
- DSSTox Substance ID:DTXSID80930735
- Nikkaji Number:J45.982H
- Wikidata:Q27116453
- Metabolomics Workbench ID:55094
- ChEMBL ID:CHEMBL19969
- Mol file:3886-69-9.mol
Synonyms:3886-69-9;(R)-(+)-1-Phenylethylamine;(R)-1-phenylethanamine;(1R)-1-phenylethanamine;(R)-1-Phenylethylamine;(R)-(+)-alpha-Methylbenzylamine;D-alpha-Methylbenzylamine;(1R)-1-phenylethan-1-amine;(R)-alpha-Methylbenzenemethanamine;1-Phenethylamine, (+)-;(R)-1-phenylethan-1-amine;(1R)-1-phenylethylamine;UNII-V022ZK8GZ5;CHEMBL19969;(alphaR)-alpha-methylbenzenemethanamine;V022ZK8GZ5;(R)-(+)-1-Methylbenzylamine;MFCD00064405;R-(+)-ALPHA-METHYLBENZYLAMINE;(R)-alpha-methylbenzylamine;(1R)-(+)-1-Phenylethylamine;CHEBI:35322;(+)-(R)-alpha-methylbenzylamine;Benzenemethanamine, .alpha.-methyl-, (.alpha.R)-;EINECS 223-423-4;[R]-1-phenylethylamine;Benzenemethanamine, alpha-methyl-, (alphaR)-;EC 223-423-4;[R]-(+)-1-phenylethylamine;R(+)-a- phenylethylamine;R-Alfa-Methylbenzylamine;(R)-a-Methylbenzylamine;R(+)-|A-phenylethylamine;(R)-(+)-?-Methylbenzylamine;QSC;(r)-phenylethylamine;Benzenemethanamine, .alpha.-methyl-, (R)-;d-1-phenylethylamine;(+)-1-phenethylamine;(R)-2-phenylethylamine;r-(+)-methylbenzylamine;(R)1-Phenyl-Ethylamine;(R)-1-phenylethylarnine;(r)-1-phenyl ethylamine;1(r)-phenyl ethyl amine;r(+)-1-phenylethylamine;(R)-1-phenyl-ethylamine;(R)alpha-methylbenzylamine;(+)-alpha-phenylethylamine;(r)-1-phenyl-ethyl-amine;(1 R)-1-phenylethanamine;(1R)-1-phenyl-ethylamine;(R)-(1-phenylethyl)amine;r(+)alpha-methylbenzylamine;(R)-alpha-methylbenzylarnine;SCHEMBL42393;(r)-(+)-1-phenethylamine;(R)-1-(phenyl)-ethylamine;(R)-alpha-methyl benzylamine;[(1R)-1-phenylethyl]amine;alpha-Formylmandeloyl chloride;(r)-(+)-a-methylbenzylamine;(1R)-1-phenyl-1-ethanamine;(R)-(-)-1-phenylethylamine;D-(+)-2-Amino-1-Butanol;R-(+)-alpha methylbenzylamine;SCHEMBL4165369;D-.ALPHA.-PHENETHYLAMINE;(R)-(+)-|A-Methylbenzylamine;DTXSID80930735;(R)-(-)-alpha-methylbenzylamine;(R)-(+)-alpha-methyl benzylamine;(R)-(+)-alpha-methyl-benzylamine;(R)-(+)-alpha-methylbenzyl amine;D-.ALPHA.-METHYLBENZYLAMINE;(R)-(+)- alpha -Methylbenzylamine;BDBM50028628;(R)-(+)-1-PHENYLETHANAMINE;AKOS005256786;AC-8773;CS-W008645;(+)-(R)-alpha-methylbenzenemethanamine;(+)-(R)-alpha-methyl-benzenemethanamine;(R)-(+)-alpha-Methylbenzylamine, 98%;A6546;AM20060613;P0794;EN300-67366;D77692;.ALPHA.-METHYLBENZYLAMINE (+)-FORM [MI];Q-200619;Q-200923;Q27116453;F8889-8738;Z1079183182;(R)-(+)-alpha-Methylbenzylamine, >=99%, ChiraSelect(TM);(R)-(+)-alpha-Methylbenzylamine, ChiPros(R), produced by BASF, >=99.0%;(R)-(+)-alpha-Methylbenzylamine, for chiral derivatization, >=99.0%;Levetiracetam impurity E, European Pharmacopoeia (EP) Reference Standard;(R)-(+)-alpha-Methylbenzylamine, purum, >=98.0% (sum of enantiomers, GC);(alphaR)-alpha-Methyl-benzenemethanamine (+)-alpha-Phenethylamine (R)-1-Amino-1-phenylethane